Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D02QQT
|
|||
| Former ID |
DIB008277
|
|||
| Drug Name |
Quattvaxem
|
|||
| Synonyms |
DTwPHib-CRM197 conjugate vaccine; DPT-Hib vaccine, Chiron; DTP-Hib vaccine, Chiron; Diphtheria, tetanus, pertussis, Haemophilus influenzae b vaccine (CRM-197 adjuvant), Chiron
Click to Show/Hide
|
|||
| Drug Type |
Vaccine
|
|||
| Indication | Bordetella pertussis infection [ICD-11: 1C12.0; ICD-10: A37.0] | Approved | [1] | |
| Company |
Chiron Corp
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Cell mediated immunity response (CMIR) | Target Info | . | [1], [2] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015 | |||
| REF 2 | Double-blind study comparing the immunogenicity of a licensed DTwPHib-CRM197 conjugate vaccine (Quattvaxem) with three investigational, liquid formulations using lower doses of Hib-CRM197 conjugate. Vaccine. 2005 Feb 25;23(14):1715-9. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.